Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP244407.RAMkjx06wJ81qAEFIg6MX9G6m-T-8HYsDvoAwTHhsUaXM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP244407.RAMkjx06wJ81qAEFIg6MX9G6m-T-8HYsDvoAwTHhsUaXM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP244407.RAMkjx06wJ81qAEFIg6MX9G6m-T-8HYsDvoAwTHhsUaXM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP244407.RAMkjx06wJ81qAEFIg6MX9G6m-T-8HYsDvoAwTHhsUaXM130_provenance.
- NP244407.RAMkjx06wJ81qAEFIg6MX9G6m-T-8HYsDvoAwTHhsUaXM130_assertion description "[Human breast carcinoma (MCF7-MLNr) cells resistant to the bifunctional drugs L-phenylalanine mustard (L-PAM, 5-fold resistance), mechlorethamine (9-fold), cisplatin (3-fold), and BCNU (3-fold) were used to investigate the role of DNA repair in the development of resistance to alkylating agents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP244407.RAMkjx06wJ81qAEFIg6MX9G6m-T-8HYsDvoAwTHhsUaXM130_provenance.
- NP244407.RAMkjx06wJ81qAEFIg6MX9G6m-T-8HYsDvoAwTHhsUaXM130_assertion evidence source_evidence_literature NP244407.RAMkjx06wJ81qAEFIg6MX9G6m-T-8HYsDvoAwTHhsUaXM130_provenance.
- NP244407.RAMkjx06wJ81qAEFIg6MX9G6m-T-8HYsDvoAwTHhsUaXM130_assertion SIO_000772 7491121 NP244407.RAMkjx06wJ81qAEFIg6MX9G6m-T-8HYsDvoAwTHhsUaXM130_provenance.
- NP244407.RAMkjx06wJ81qAEFIg6MX9G6m-T-8HYsDvoAwTHhsUaXM130_assertion wasDerivedFrom befree-20140225 NP244407.RAMkjx06wJ81qAEFIg6MX9G6m-T-8HYsDvoAwTHhsUaXM130_provenance.
- NP244407.RAMkjx06wJ81qAEFIg6MX9G6m-T-8HYsDvoAwTHhsUaXM130_assertion wasGeneratedBy ECO_0000203 NP244407.RAMkjx06wJ81qAEFIg6MX9G6m-T-8HYsDvoAwTHhsUaXM130_provenance.
- befree-20140225 importedOn "2014-02-25" NP244407.RAMkjx06wJ81qAEFIg6MX9G6m-T-8HYsDvoAwTHhsUaXM130_provenance.